blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2550046

EP2550046 - DISPOSABLE SYRINGE APPLICATORS FOR MULTI-COMPONENT FORMULATIONS [Right-click to bookmark this link]
Former [2013/05]DISPOSABLE SYRINGE APPLICATORS FOR MULTI-COMPONENT FORMULATIONS, AND METHODS OF USE THEREOF
[2019/02]
StatusNo opposition filed within time limit
Status updated on  28.02.2020
Database last updated on 24.08.2024
FormerThe patent has been granted
Status updated on  22.03.2019
FormerGrant of patent is intended
Status updated on  02.01.2019
FormerExamination is in progress
Status updated on  24.02.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Hyperbranch Medical Technology, Inc.
801 Capitola Drive, 4
Durham, NC 27713-4410 / US
[2013/05]
Inventor(s)01 / BUTLIN, Jared, D.G.
6 Shelter Cove
Durham, NC 27713 / US
02 / D'ALESSIO, Keith, R.
305 Jaslie Drive
Carey, NC 27511 / US
 [2013/05]
Representative(s)HGF
1 City Walk
Leeds LS11 9DX / GB
[N/P]
Former [2019/17]HGF Limited
1 City Walk
Leeds LS11 9DX / GB
Former [2013/30]Atkinson, Jonathan David Mark, et al
Harrison Goddard Foote LLP
Belgrave Hall
Belgrave Street
Leeds LS2 8DD / GB
Former [2013/05]Harrison Goddard Foote
Belgrave Hall
Belgrave Street
Leeds
LS2 8DD / GB
Application number, filing date11759906.814.03.2011
[2019/17]
WO2011US28301
Priority number, dateUS20100316516P23.03.2010         Original published format: US 316516 P
US20110432832P14.01.2011         Original published format: US 432832 P
[2013/05]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011119360
Date:29.09.2011
Language:EN
[2011/39]
Type: A1 Application with search report 
No.:EP2550046
Date:30.01.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 29.09.2011 takes the place of the publication of the European patent application.
[2013/05]
Type: B1 Patent specification 
No.:EP2550046
Date:24.04.2019
Language:EN
[2019/17]
Search report(s)International search report - published on:US29.09.2011
(Supplementary) European search report - dispatched on:EP30.11.2015
ClassificationIPC:A61M5/315, A61B17/00
[2016/01]
CPC:
A61B17/00491 (EP,US); A61M5/19 (EP,US); A61B2017/00495 (EP,US);
A61B2017/00522 (EP,US); A61M2005/341 (EP,US); A61M5/204 (EP,US);
A61M5/284 (EP,US) (-)
Former IPC [2013/05]A61M5/315
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/05]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:EINWEGSPRITZENAPPLIKATOREN FÜR FORMULIERUNGEN AUS MEHREREN BESTANDTEILEN[2019/02]
English:DISPOSABLE SYRINGE APPLICATORS FOR MULTI-COMPONENT FORMULATIONS[2019/02]
French:APPLICATEURS JETABLES À SERINGUE POUR DES FORMULATIONS À COMPOSANTS MULTIPLES[2019/02]
Former [2013/05]EINWEGSPRITZENAPPLIKATOREN FÜR FORMULIERUNGEN AUS MEHREREN BESTANDTEILEN UND VERWENDUNGSVERFAHREN DAFÜR
Former [2013/05]DISPOSABLE SYRINGE APPLICATORS FOR MULTI-COMPONENT FORMULATIONS, AND METHODS OF USE THEREOF
Former [2013/05]APPLICATEURS JETABLES À SERINGUE POUR DES FORMULATIONS À COMPOSANTS MULTIPLES, ET LEURS PROCÉDÉS D'UTILISATION
Entry into regional phase19.10.2012National basic fee paid 
19.10.2012Search fee paid 
19.10.2012Designation fee(s) paid 
19.10.2012Examination fee paid 
Examination procedure19.10.2012Examination requested  [2013/05]
07.07.2016Amendment by applicant (claims and/or description)
23.02.2017Invitation to indicate the basis for amendments (Time limit: M01)
14.03.2017Reply to an invitation to indicate the basis for amendments
11.05.2017Despatch of a communication from the examining division (Time limit: M06)
17.11.2017Reply to a communication from the examining division
04.12.2018Cancellation of oral proceeding that was planned for 14.12.2018
14.12.2018Date of oral proceedings (cancelled)
03.01.2019Communication of intention to grant the patent
13.03.2019Fee for grant paid
13.03.2019Fee for publishing/printing paid
13.03.2019Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.05.2017
Opposition(s)27.01.2020No opposition filed within time limit [2020/14]
Fees paidRenewal fee
11.03.2013Renewal fee patent year 03
12.03.2014Renewal fee patent year 04
10.03.2015Renewal fee patent year 05
10.03.2016Renewal fee patent year 06
10.03.2017Renewal fee patent year 07
13.03.2018Renewal fee patent year 08
13.03.2019Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.03.2011
AL24.04.2019
AT24.04.2019
CY24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
IT24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
MK24.04.2019
MT24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
[2022/32]
Former [2022/27]HU14.03.2011
AL24.04.2019
AT24.04.2019
CY24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
IT24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
MT24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/49]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
IT24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/25]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
IT24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/17]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
IT24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/14]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
IT24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SK24.04.2019
SM24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/12]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
IT24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SK24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/11]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SK24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/10]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/09]AL24.04.2019
CZ24.04.2019
DK24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RS24.04.2019
SE24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/04]AL24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RS24.04.2019
SE24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2019/52]AL24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RS24.04.2019
SE24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
PT24.08.2019
Former [2019/51]AL24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
RS24.04.2019
SE24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
PT24.08.2019
Former [2019/50]AL24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
RS24.04.2019
SE24.04.2019
NO24.07.2019
GR25.07.2019
PT24.08.2019
Former [2019/49]AL24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
NL24.04.2019
SE24.04.2019
NO24.07.2019
PT24.08.2019
Former [2019/48]ES24.04.2019
FI24.04.2019
LT24.04.2019
NL24.04.2019
SE24.04.2019
NO24.07.2019
PT24.08.2019
Former [2019/47]ES24.04.2019
FI24.04.2019
LT24.04.2019
NL24.04.2019
NO24.07.2019
Former [2019/44]NL24.04.2019
Documents cited:Search[X]US2002074054  (ZINGER FREDDY [IL]) [X] 13,18 * paragraph [0034] - paragraph [0037] * * figures 5-12 *;
 [X]EP0925026  (OMRIX BIOPHARM SA [BE]) [X] 13,18 * paragraph [0016] - paragraph [0020] * * figure 1 *;
 [X]US6565539  (ZINGER FREDDY [IL], et al) [X] 13,18 * column 6, line 8 - line 27 * * column 7, line 8 - line 27 * * figures 1-9 *;
 [I]US2009062741  (SMITH EMERY [US], et al) [I] 13,18 * paragraph [0029] - paragraph [0049] * * figures 1-4 *;
 [I]US2008161757  (NAYAK ASHA [US], et al) [I] 13,18 * paragraph [0030] * * paragraph [0039] - paragraph [0040] * * figures 1A-2 *;
 [A]EP0996474  (UNITED STATES SURGICAL CORP [US], et al) [A] 13,18 * the whole document *
International search[Y]US2006079834  (TENNICAN PATRICK O [US], et al);
 [Y]US5360410  (WACKS JONATHAN L [US]);
 [Y]US2010010473  (D ALESSIO KEITH R [US], et al);
 [Y]US2003114797  (VAILLANCOURT VINCENT L [US], et al);
 [Y]US2002087144  (ZINGER FREDDY [IL], et al)
ExaminationWO9720585
by applicantUS5080649
 US2007276322
 US5474540
 US4874368
 US5368563
 US4735616
 US6238372
 US6136326
 US6743858
 US6248800
 US6143805
 US6579916
    - REP. PROG. PHYS., (1998), vol. 61, pages 1325 - 1365
    - BIOTECHNOL. BIOENG., (2005), vol. 90, pages 715 - 722
    - BIOTECHNOL. BIOENG., (2003), vol. 83, pages 168 - 172
    - BIOTECHNOLOGY LETTERS, (2003), vol. 25, pages 1661 - 1665
    - BIOTECHNOL. PROG., (2002), vol. 18, pages 1082 - 1086
    - CHEM. COMMUN., (1999), pages 1585 - 1586
    - PROC. NAT. ACAD. SCI. USA, (2006), vol. 103, pages 17667 - 17671
    - BIOORGANIC CHEMISTRY, (1994), vol. 22, pages 318 - 327
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.